DeepMed Research

CALIFORNIA RETINA CONSULTANTS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website: https://californiaretina.com/

Clinical Trials

Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study)

Phase 4

Completed

Conditions: Diabetic Retinopathy
Diabetic Macular Edema
Age-related Macular Degeneration

Interventions: Other: Povidone Iodine
Other: Hypochlorous Acid

First Posted Date: 2019-07-12

Last Posted Date: 2020-03-10

Lead Sponsor: California Retina Consultants

Target Recruit Count: 50

Registration Number: NCT04018482

Locations: 🇺🇸
California Retina Consultants, Santa Barbara, California, United States

Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema

Phase 4

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: Intravitreal anti-VEGF injection
Drug: Dexamethasone intravitreal implant (0.7 mg)

First Posted Date: 2015-06-15

Last Posted Date: 2019-02-19

Lead Sponsor: California Retina Consultants

Target Recruit Count: 40

Registration Number: NCT02471651

Locations: 🇺🇸
California Retina Consultants, Santa Maria, California, United States

Variable Interval Versus Set Interval Aflibercept for DME

Phase 4

Completed

Conditions: Cystoid Macular Edema
Diabetic Macular Edema

Interventions: Drug: Intravitreal Aflibercept Injection

First Posted Date: 2015-03-19

Last Posted Date: 2019-01-03

Lead Sponsor: California Retina Consultants

Target Recruit Count: 50

Registration Number: NCT02392364

Locations: 🇺🇸
California Retina Consultants - Bakersfield, Bakersfield, California, United States
🇺🇸
California Retina Consultants - Santa Barbara Office, Santa Barbara, California, United States

Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF

Phase 1

Completed

Conditions: Diabetic Macular Edema
Retinal Vein Occlusion
Age-related Macular Degeneration

Interventions: Biological: Blood Sample Collection
Drug: Bevacizumab
Drug: Ranibizumab
Drug: Aflibercept

First Posted Date: 2014-04-21

Last Posted Date: 2016-05-19

Lead Sponsor: California Retina Consultants

Target Recruit Count: 56

Registration Number: NCT02118831

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab

Phase 4

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: Intravitreal ranibizumab 0.3mg

First Posted Date: 2014-04-08

Last Posted Date: 2018-12-19

Lead Sponsor: California Retina Consultants

Target Recruit Count: 40

Registration Number: NCT02107131

Locations: 🇺🇸
California Retina Consultants, Visalia, California, United States
🇺🇸
California Retina Consultants - Santa Barbara Office, Santa Barbara, California, United States
🇺🇸
California Retina Consultants - Bakersfield, Bakersfield, California, United States

Analysis of Aqueous and Vitreous Humor

Phase 2

Conditions: Proliferative Diabetic Retinopathy
Macular Degeneration
Macular Hole
Neovascular Glaucoma

Interventions: Other: No Ranibizumab
Drug: Ranibizumab

First Posted Date: 2014-02-20

Last Posted Date: 2017-03-01

Lead Sponsor: California Retina Consultants

Target Recruit Count: 45

Registration Number: NCT02067013

Locations: 🇺🇸
California Retina Consultants - Santa Barbara Office, Santa Barbara, California, United States

Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab

Phase 1

Completed

Conditions: Diabetic Macular Edema

Interventions: Drug: Ranibizumab

First Posted Date: 2011-02-10

Last Posted Date: 2016-04-22

Lead Sponsor: California Retina Consultants

Target Recruit Count: 43

Registration Number: NCT01292798

Locations: 🇺🇸
California Retina Consultants, Santa Maria, California, United States
🇺🇸
Retina Institute of Hawai'i, Honolulu, Hawaii, United States

Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion

Phase 1

Completed

Conditions: Central Retinal Vein Occlusion

Interventions: Drug: Ranibizumab (Lucentis)

First Posted Date: 2009-12-09

Last Posted Date: 2013-12-12

Lead Sponsor: California Retina Consultants

Target Recruit Count: 20

Registration Number: NCT01028248

Locations: 🇺🇸
California Retina Consultants, Santa Maria, California, United States

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Phase 2

Completed

Conditions: Age Related Macular Degeneration
Macular Edema
Choroidal Neovascularization

Interventions: Drug: Bevacizumab
Device: verteporfin photodynamic therapy reduced fluence
Device: verteporfin photodynamic therapy standardfluence

First Posted Date: 2008-08-08

Last Posted Date: 2016-04-20

Lead Sponsor: California Retina Consultants

Target Recruit Count: 22

Registration Number: NCT00729846

Locations: 🇺🇸
California Retina Consultants, Santa Barbara, California, United States

Lucentis for Central Retinal Vein Occlusion (CRVO)

Phase 1

Completed

Conditions: Central Retinal Vein Occlusion

Interventions: Drug: Ranibizumab

First Posted Date: 2006-12-04

Last Posted Date: 2013-12-12

Lead Sponsor: California Retina Consultants

Target Recruit Count: 20

Registration Number: NCT00406796

Locations: 🇺🇸
California Retina Consultants, Santa Maria, California, United States

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy